Primidone
Back to searchMolecule Structure
Scientific Name
Primidone
Description of the Drug
Primidone is an antiepileptic used to treat grand mal, psychomotor, and focal epileptic seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00794
http://www.drugbank.ca/drugs/DB00794
Brand Name(s)
Lepsiral, Liskantin, Mysoline, Neurosyn, Primidone
Company Owner(s)
Rubicon Research Private Ltd, Nuro Pharma Llc, Hikma International Pharmaceuticals Llc, Oxford Pharmaceuticals Llc, Watson Laboratories Inc, Anda Repository Llc, Dr Reddys Laboratories Ltd, Valeant Pharmaceuticals International, Amneal Pharmaceutical, Lannett Co Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34221 | |
| PharmGKB | PA451105 | |
| Human Metabolome Database | HMDB0014932 | |
| DrugBank | DB00794 | |
| PubChem: Thomson Pharma | 15121366 | |
| PubChem | 4909 | |
| Mcule | MCULE-2519004832 | |
| LINCS | LSM-2700 | |
| Nikkaji | J3.260C | |
| BindingDB | 50248152 | |
| EPA CompTox Dashboard | DTXSID7023510 | |
| DrugCentral | 2267 | |
| Brenda | 33787 | |
| ChemicalBook | CB1161900 | |
| Guide to Pharmacology | 5338 | |
| rxnorm | PRIMIDONE | MYSOLINE |
| KEGG Ligand | C07371 | |
| ChEBI | 8412 | |
| ZINC | ZINC000000001979 |
